Rabies Vaccine Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2020 - 2025

Report Code: HCR 43563 Report Format: PDF + Excel (Delivery in 48 Hrs)

Overview

Rabies Vaccine Market is estimated to reach $970 million by 2025, and is observed to grow at a CAGR of 6% during forecast period of 2019-2025. Growing awareness on prevention of rabies, and support from government are the key factors driving the growth for the rabies vaccine market.

Key Takeaways

  • The Rabies Vaccine Market size during 2018 is $635.6 million. The Vero Cells Rabies vaccine segment has the highest revenue by product segment. It is positioned the highest in Rabies Vaccine market share, due to its feasibility and wider application.
  • North America held the largest market share with 30% in terms of revenue owing to its development in healthcare sector.
  • Education on the causative and preventive measures of rabies, and increased initiatives by government have driven the market. But lack of resources and adequate supply of vaccines in developing nations, hinder the market growth in such regions

Product Type - Segment Analysis

Vaccines are prepared using cellular substrates such as hamster kidney cells, chick embryo cells, fetal rhesus lung cells, Vero cells and others. The Vero Cell Babies vaccine segment accounted for the largest market share of rabies vaccine market based on product type. This is owing to the feasibility of the Vero Cells. Also, these vaccines can be used for Pre-exposure Prophylaxis and Post-exposure Prophylaxis. This Vero cell vaccines are also safe and have high immunogenicity.

Application - Segment Analysis

Rabies is responsible for more than 59,000 deaths, every year. The heavy expenditure for treatment of rabies cases can be reduced by Pre-exposure Prophylaxis. This preventive vaccine is used by people who are at risk of being infected by rabies as their work exposes them to the virus. Those patients with bite or non-bite exposures are given Post-exposure Prophylaxis to control and treat the infection after it has affected the body. Rabies immunoglobulin is given post exposure to neutralize rabies at the wound site, and is then followed by vaccination.  Post-exposure Prophylaxis is projected to be growing at a CAGR of 4.7%. The post-exposure treatment has also considerably reduced the number of rabies related deaths, even though cases of rabies are high.

Geography - Segment Analysis

North America occupies the largest share by geography, in Rabies Vaccine Market. This is because, the number of deaths attributed to rabies have declined over the past few years. This reduction is due to animal vaccination programs and development of human rabies vaccines by these nations. Government support and establishment of a number of pharmaceutical companies in these regions, also contributes to the rabies vaccine market. North America has a well-established healthcare infrastructure and higher awareness among the people as well as healthcare professionals, which further make the rabies vaccine market dominant.

Drivers – Rabies Vaccine Market

  • Increased government initiatives

With the rise in number of deaths due to rabies, government has increased their efforts to prevent its spreading. The government has educated people and also taken measures to vaccinate animals, thus having reduced the number of rabies cases. This has driven the need for rabies vaccines and hence the rabies vaccines market.

  • Increase in the adoption of strays as pets

The increase in adoption of stray animals has also contributed to the rabies vaccine market. As people are well educated about the cause of rabies and its prevention, they have started vaccinating their pets. Adoption of pets has increased which requires more vaccination to be done for adopted pets. Canine vaccines contained a preservative, thimerosal, which was a derivative of mercury. It was harmful to pets and humans. So now most vaccines are devoid of thimerosal. Hence thimerosal or mercury-free vaccines have more potential to grow in demand.

Challenges – Rabies Vaccine Market

  • Fewer regulations in low income countries 

Lower income countries have less resources to regulate the virus. The animal control in such nations is very difficult owing to their huge population of stray animals. Also, people in such nations are not completely educated about the disease and its prevention. Some remote areas also lack supply of vaccines which restrain the market further.

Rabies Vaccine Industry Outlook

Research & development and strategic alliances are some of the key strategies adopted by players in the rabies vaccine market. Rabies Vaccine top 10 companies are AstraZeneca, Sanofi Pasteur Inc., Novartis Vaccines and Diagnostics Ltd., Cadila Pharmaceuticals Ltd., GlaxoSmithKline Biologicals, Merck & Co Inc., Wyeth pharmaceuticals, Berna Biotech Ltd., and Medimmune LLC., CSC Pharmaceutical International, and others.

Acquisitions/Research & Development Launches:

  • During February, 2019, GlaxoSmithKline (GSK) divested its Chiron Behring Vaccines unit (India, to a clinical biotechnology company Bharat Biotech (India). Chiron Behring Vaccines is one of the largest manufacturer of rabies vaccines. Bharat Biotech can enhance their product portfolio and increase its availability to tackle public health.

Rabies Vaccine Market Research Scope: 

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Rabies Vaccine market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. 

1. Rabies Vaccine Market - Overview
        1.1 Definitions and Scope
2. Rabies Vaccine Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Rabies Vaccine Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Rabies Vaccine Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Rabies Vaccine Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Rabies Vaccine Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Rabies Vaccine Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Rabies Vaccine Market - By Product Type (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Product Segment Analysis
            8.3.1 Vero Cell Rabies Vaccine
            8.3.2 Baby Hamster Kidney
            8.3.3 Chick Embryo Cell Rabies Vaccine
9. Rabies Vaccine Market - By Type (Market Size -$Million / $Billion)
10. Rabies Vaccine - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
            10.3.1 Pre-Exposure Prophylaxis
            10.3.2 Post-Exposure Prophylaxis
11. Rabies Vaccine- By Geography (Market Size -$Million / $Billion)
        11.1 Rabies Vaccine Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Rabies Vaccine- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Rabies Vaccine- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Rabies Vaccine - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Rabies Vaccine - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Rabies Vaccine Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Rabies Vaccine Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Rabies Vaccine Market - Key Company List by Country Premium
15. Rabies Vaccine Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Berna Biotech Ltd
        15.3 Cadila Pharmaceutical Ltd.
        15.4 Csc Pharmaceutical International
        15.5 Glaxosmithkline Biologicals
        15.6 Medimmune Llc
        15.7 Merck Co Inc
        15.8 Novartis Vaccine And Diagnostics Ltd
        15.9 Sanofi Pasteur, Inc
        15.10 Serum Institute Of India
        15.11 Wyeth Pharmaceutical
        15.12 Company 12
        15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Rabies Vaccine Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Rabies Vaccine Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Rabies Vaccine Market, By Product Type Market 2019-2024 ($M)
1.1 Vero Cell Rabies Vaccine Market 2019-2024 ($M) - Global Industry Research
1.2 Baby Hamster Kidney Market 2019-2024 ($M) - Global Industry Research
1.3 Chick Embryo Cell Rabies Vaccine Market 2019-2024 ($M) - Global Industry Research
2.Global Rabies Vaccine Market, By Product Type Market 2019-2024 (Volume/Units)
2.1 Vero Cell Rabies Vaccine Market 2019-2024 (Volume/Units) - Global Industry Research
2.2 Baby Hamster Kidney Market 2019-2024 (Volume/Units) - Global Industry Research
2.3 Chick Embryo Cell Rabies Vaccine Market 2019-2024 (Volume/Units) - Global Industry Research
3.North America Rabies Vaccine Market, By Product Type Market 2019-2024 ($M)
3.1 Vero Cell Rabies Vaccine Market 2019-2024 ($M) - Regional Industry Research
3.2 Baby Hamster Kidney Market 2019-2024 ($M) - Regional Industry Research
3.3 Chick Embryo Cell Rabies Vaccine Market 2019-2024 ($M) - Regional Industry Research
4.South America Rabies Vaccine Market, By Product Type Market 2019-2024 ($M)
4.1 Vero Cell Rabies Vaccine Market 2019-2024 ($M) - Regional Industry Research
4.2 Baby Hamster Kidney Market 2019-2024 ($M) - Regional Industry Research
4.3 Chick Embryo Cell Rabies Vaccine Market 2019-2024 ($M) - Regional Industry Research
5.Europe Rabies Vaccine Market, By Product Type Market 2019-2024 ($M)
5.1 Vero Cell Rabies Vaccine Market 2019-2024 ($M) - Regional Industry Research
5.2 Baby Hamster Kidney Market 2019-2024 ($M) - Regional Industry Research
5.3 Chick Embryo Cell Rabies Vaccine Market 2019-2024 ($M) - Regional Industry Research
6.APAC Rabies Vaccine Market, By Product Type Market 2019-2024 ($M)
6.1 Vero Cell Rabies Vaccine Market 2019-2024 ($M) - Regional Industry Research
6.2 Baby Hamster Kidney Market 2019-2024 ($M) - Regional Industry Research
6.3 Chick Embryo Cell Rabies Vaccine Market 2019-2024 ($M) - Regional Industry Research
7.MENA Rabies Vaccine Market, By Product Type Market 2019-2024 ($M)
7.1 Vero Cell Rabies Vaccine Market 2019-2024 ($M) - Regional Industry Research
7.2 Baby Hamster Kidney Market 2019-2024 ($M) - Regional Industry Research
7.3 Chick Embryo Cell Rabies Vaccine Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Rabies Vaccine Market Revenue, 2019-2024 ($M)
2.Canada Rabies Vaccine Market Revenue, 2019-2024 ($M)
3.Mexico Rabies Vaccine Market Revenue, 2019-2024 ($M)
4.Brazil Rabies Vaccine Market Revenue, 2019-2024 ($M)
5.Argentina Rabies Vaccine Market Revenue, 2019-2024 ($M)
6.Peru Rabies Vaccine Market Revenue, 2019-2024 ($M)
7.Colombia Rabies Vaccine Market Revenue, 2019-2024 ($M)
8.Chile Rabies Vaccine Market Revenue, 2019-2024 ($M)
9.Rest of South America Rabies Vaccine Market Revenue, 2019-2024 ($M)
10.UK Rabies Vaccine Market Revenue, 2019-2024 ($M)
11.Germany Rabies Vaccine Market Revenue, 2019-2024 ($M)
12.France Rabies Vaccine Market Revenue, 2019-2024 ($M)
13.Italy Rabies Vaccine Market Revenue, 2019-2024 ($M)
14.Spain Rabies Vaccine Market Revenue, 2019-2024 ($M)
15.Rest of Europe Rabies Vaccine Market Revenue, 2019-2024 ($M)
16.China Rabies Vaccine Market Revenue, 2019-2024 ($M)
17.India Rabies Vaccine Market Revenue, 2019-2024 ($M)
18.Japan Rabies Vaccine Market Revenue, 2019-2024 ($M)
19.South Korea Rabies Vaccine Market Revenue, 2019-2024 ($M)
20.South Africa Rabies Vaccine Market Revenue, 2019-2024 ($M)
21.North America Rabies Vaccine By Application
22.South America Rabies Vaccine By Application
23.Europe Rabies Vaccine By Application
24.APAC Rabies Vaccine By Application
25.MENA Rabies Vaccine By Application
26.Serum Institute Of India, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Sanofi Pasteur, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Novartis Vaccine And Diagnostics Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Cadila Pharmaceutical Ltd., Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Glaxosmithkline Biologicals, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Merck Co Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Wyeth Pharmaceutical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Berna Biotech Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Csc Pharmaceutical International, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Medimmune Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)